Incident and Prevalent Use of Generic Drugs for Overactive Bladder

Basic Details
Date Posted
Monday, December 11, 2017
Status
In progress
Medical Product
darifenacin hydrobromide
fesoterodine fumarate
oxybutynin chloride
solifenacin succinate
tolterodine tartrate
trospium chloride
Description

These reports examine the prevalent and incident use of six drug products used for overactive bladder in the Mini-Sentinel Distributed Database (MSDD). Results were generated using the Mini-Sentinel Distributed Query Tool. Queries were run against the Dispensing Summary Table and distributed on June 4, 2013 to 17 Data Partners; this report includes information from 17 Data Partners.

Deliverables (1)
Mini-Sentinel Summary Table Report: Prevalent Use of Generic Drugs for Overactive Bladder
Additional Details
FDA Center
CDER
Time Period
2001 - 2012
Study Type
Summary Table
Assessment Type
Exploratory Analyses
Data Sources
Mini-Sentinel Distributed Database (MSDD)